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2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) is among
the most potent environmentally toxic compounds.
Serum metabolomics identified azelaic acid mono-
esters as significantly increased metabolites after
TCDD treatment, due to downregulation of hepatic
carboxylesterase 3 (CES3, also known as triglyc-
eride hydrolase) expression in an arylhydrocarbon
receptor (AhR)-dependent manner in mice. The
decreased CES3 expression was accomplished by
TCDD-stimulated TGFb-SMAD3 and IL6-STAT3
signaling, but not by direct AhR signaling. Methio-
nine- and choline-deficient (MCD) diet-treated mice
also showed enhanced serum azelaic acid mono-
ester levels after attenuation of hepatic CES3
expression, while db/db mice did not, thus sug-
gesting an association with steatohepatitis. Forced
expression of CES3 reversed serum azelaic acid
monoester/azelaic acid ratios and hepatic TGFb
mRNA levels in TCDD- and MCD diet-treated
mice and ameliorated steatohepatitis induced by
MCD diet. These results support the view that aze-
laic acid monoesters are possible indicators of
TCDD exposure and steatohepatitis and suggest
a link between CES3, TGFb, and steatohepatitis.
INTRODUCTION
A number of chemical contaminants highly prevalent in the envi-
ronment elicit some or all of their toxicity through the arylhydro-
carbon receptor (AhR), a ligand-activated transcription factor.
Activated AhR forms a heterodimer together with the AhR
nuclear translocator (ARNT) and binds to xenobiotic response
elements in the promoter regions of target resulting in induction
or inhibition of expression. Among the AhR target genes are the634 Cell Metabolism 16, 634–644, November 7, 2012 ª2012 Elseviercytochrome P450 (CYP) 1A1, CYP1A2, and CYP1B1 (Nebert
et al., 2004). Many polycyclic aromatic hydrocarbons and poly-
chlorinated biphenyls are activators of AhR/ARNT signaling
and considered carcinogenic either individually or as part of
mixtures. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) is among
the most notorious; accidental exposure of humans to TCDD is
associated with birth defects, increased risk of cancer, and the
development of chronic disease in exposed individuals. In
animal studies, TCDD exposure leads to a variety of toxicities
in the immune system and liver, and birth defects when adminis-
tered during pregnancy (Rifkind, 2006). The mechanisms of
how TCDD induces toxicities have been investigated in mouse
models; notably, the Ahr-null (Ahr/) mouse is resistant to
thymus atrophy, hepatomegaly, pulmonary lesion, immuno-
toxicity, and teratogenesis (Fernandez-Salguero et al., 1995,
1996; Peters et al., 1999; Thomae et al., 2004; Thurmond et al.,
2000; Vorderstrasse et al., 2001).
For development of a better understanding of the biochemical
events underlying TCDD toxicity, global gene expression was
investigated by microarray analysis (Fletcher et al., 2005; Hanlon
et al., 2005). Another approach to unravel the mechanism of
toxicity is to determine the effect of TCDD on serum and urine
metabolites. Metabolomics, based on ultra performance liquid
chromatography coupled with electrospray ionization quadru-
pole time-of-flight mass spectrometry (UPLC-ESI-QTOFMS),
is a potent tool for the detection and characterization of small
organic chemicals in biological matrices (Idle and Gonzalez,
2007; Johnson et al., 2012). Recently, TCDD-induced changes
in serum metabolites were analyzed and TCDD exposure was
reported to enhance serum lysophosphatidylcholine (22:5) and
lysophosphatidylethanolamine (18:1, 18:2, and 18:3) and atten-
uate serum fatty acids (eicosapentaenoic acid and docosahex-
aenoic acid) (Lin et al., 2011). However, it was unclear whether
these metabolites were involved in TCDD toxicity.
In the current study, dose- and time-dependent changes in
serum metabolites after TCDD exposure were investigated
with UPLC-ESI-QTOFMS. In addition, mouse models of AhR/
ARNT signaling were used to clarify the mechanism. These
combinational analyses provided early biomarkers associatedInc.
Figure 1. Identification of Serum Metabo-
lites Altered by TCDD Exposure
(A) PLS-DA of the serum metabolites between OIL
(vehicle, opened circle) and TCDD (3 days later
[D3], gray closed circle; 7 days later [D7], black
closed circle).
(B) Loading plot of the PLS-DA.
(C) Time course of serum TCDD markers (M0, M1,
and M2) after exposure to 200 mg/kg TCDD.
Amounts were normalized to 4-chloropropamide.
Data represent the mean (n = 5–9).
(D) Chemical structures of identified TCDD
markers (M0 and M2).
(E and F) Quantification of azelaic acid (Az) and M2
levels in serum (C57BL/6) after TCDD exposure is
shown in (E). Each bar represents the mean value
and SD (n = 4–9). Serum M2 levels in Ahr/,
ArntDLiv, and ArntDIE mice are shown in (F). Each
bar represents the mean value and SD (n = 3–9).
Significance was determined by one-way ANOVA
with Dunnett’s test (E) or Bonferroni’s test (F). *p <
0.05; **p < 0.01; ***p < 0.001; NS, not significant.
See also Tables S2 and S3 and Figures S1–S3.
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of the molecular mechanism.
RESULTS
TCDDExposure Altered SerumAzelaic AcidMetabolites
Depending on Hepatic AhR/ARNT Signaling
The influence of TCDD exposure on serum metabolites was
investigated in male mice administered TCDD (10 or 200 mg/kg
body weight) or vehicle (10% DMSO/90% corn oil). Low-dose
TCDD (10 mg/kg) did not significantly change serum alanine
and aspartate aminotransferase (ALT and AST, respectively)
activities, while high-dose TCDD (200 mg/kg) increased both
markers for hepatotoxicity (Figures S1A and S1B available on-
line). Hepatic injury was observed only at high-dose TCDD (Fig-
ure S1C). Induction of hepatic expression of CYP1A1 and
CYP1A2, prototypical AhR target genes, was found with both
low- and high-dose TCDD (Figure S1D). Partial least-squares-
discriminant analysis (PLS-DA) on UPLC-ESI-QTOFMS negative
mode data from serum of mice exposed to 200 mg/kg of TCDDCell Metabolism 16, 634–644,revealed separation between the control
and TCDD groups (Figure 1A) that was
further examined in the loading plot
(Figure 1B). PLS-DA with UPLC-ESI-
QTOFMS positive mode data also
showed clear separation between the
groups (data not shown). The contribution
analysis indicated 20 ions as the top-
ranking ions giving rise to the separation
in negative and positive modes (Tables
S2 and S3). The most attenuated ion
was metabolite 0 (M0, m/z = 187.0968
at 2.12 min). In the enhanced ions group,
the top 2 ions were metabolite 1 (M1,
m/z = 273.1684 at 3.02 min) and metab-
olite 2 (M2,m/z = 245.1380 at 2.48 min). The decrease in serum
M0 levels and the increase in serumM1 and M2 levels were time
dependent after TCDD injection (Figure 1C). The identification
was performed by tandemmass spectrometry MS/MS fragmen-
tation with authentic chemicals. The MS/MS fragmentation of
M0 showed m/z = 97, 125, and 187, and the fragmentation
pattern was the same as that of authentic azelaic acid (Fig-
ure S2A, left). Thus, M0 was determined as azelaic acid (Az) (Fig-
ure 1D). The MS/MS fragmentation of M2 showed m/z = 97,
125, 187, and 245, (Figure S2A, middle) and was identified
as azelaic acid mono-hydroxypropyl ester. In addition, M2 was
determined to be a mixture of three structural isomers, nonane-
dioic acid mono-(3-hydroxypropyl) ester (M2a), nonanedioic
acid mono-(2-hydroxypropyl) ester (M2b), and nonanedioic
acid mono-(2-hydroxy-1-methylethyl) ester (M2c), using an opti-
mized UPLC-ESI-TOFMS (Figures 1D and S2B). The MS/MS
fragmentation of M1 showed m/z = 97, 125, 187, and 273
(Figure S2A, right) and M1 was expected as azelaic acid
mono-hydroxypentyl ester. The MS/MS fragmentation pattern
of the authentic chemical was the same as that of M1, but theNovember 7, 2012 ª2012 Elsevier Inc. 635
Figure 2. TCDD Exposure Lowered Micro-
somal M2 Hydrolysis Activities in the Liver
(A–C) Kinetic analysis of microsomal M2 in liver of
male C57BL/6 mouse (M2a, A; M2b, B; M2c, C).
Hydrolase activity, Vmax, and Km were estimated
as described in the Experimental Procedures.
(D–F) Changes in hepatic microsomal activity of
M2 hydrolysis after TCDD injection (C57BL/6, D;
Ahr/, E; ArntDLiv, F). Value was expressed as
ratio to the wild-type mice treated with OIL.
Each bar represents the mean value and SD (n =
3–5). Significance was determined by one-way
ANOVA with Dunnett’s test (D) or Bonferroni’s test
(E and F). *p < 0.05; **p < 0.01; ***p < 0.001; NS, not
significant.
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was not identified, although it was expected as Az ester (struc-
ture presented in Figures S2D and S2E). Serum Az and M2
levels were measured in C57BL/6 mice 7 days after TCDD
injection. TCDD exposure decreased the Az levels [OIL,
TCDD(+) and TCDD(++) was 43.8 ± 9.9, 28.3 ± 4.8, and
26.2 ± 0.8 mM, respectively] and increased the M2 levels [OIL,
TCDD(+) and TCDD(++) was 1.8 ± 1.7, 6.9 ± 3.1, and 8.8 ±
1.7 mM, respectively] in a dose-dependent manner (Figure 1E).
For determination of whether the alterations in serum metabo-
lites were dependent on AhR/ARNT signaling, TCDD was
administered to Ahr/, hepatocyte-specific Arnt null (ArntDLiv),
and intestinal epithelial cell-specific Arnt null (ArntDIE) mice.
Metabolomic analysis demonstrated that serum metabolite
changes associated with TCDD treatment in wild-type litter-
mate mice were not observed in the Ahr/ and ArntDLiv, but
were similar to wild-type mice in the ArntDIE mice (Figure S3A).
The TCDD-stimulated increase in M2 levels was attenuated in
the Ahr/ and ArntDLiv mice, but not in the ArntDIE mice (Fig-
ure 1F). Moreover, the TCDD-stimulated changes in serum
ALT activities and Az and M1 levels were not found in the636 Cell Metabolism 16, 634–644, November 7, 2012 ª2012 Elsevier Inc.Ahr/ and ArntDLiv mice, while the
changes in the ArntDIE mice were similar
to the ArntF/F mice (Figures S3B–S3D).
These results suggest that TCDD expo-
sure alters serum metabolites through
hepatic AhR/ARNT signaling and is asso-
ciated with liver injury.
TCDD Exposure Lowered Hepatic
Hydrolase Activity toward M2
after Attenuation of Hepatic
Carboxylesterase 3 Expression in
an AhR/ARNT-Dependent Manner
Kinetic analysis of M2 metabolism in
the C57BL/6 mouse was performed,
revealing maximum enzyme velocity
(Vmax) values toward M2a, M2b, and
M2c of 47.0, 42.5, and 38.0 nmol/min/mg
microsomal protein, respectively (Figures
2A–2C). The Michaelis-Menten constant
(Km) of M2a, M2b, and M2c were 79.5,
71.2, and 96.1 mM, respectively. Further-more, the metabolic activities were attenuated in a hepatic
AhR/ARNT-dependent manner (Figures 2D–2F). These results
suggest that TCDD-induced attenuation of hepatic hydrolase
activity enhances serum M2 levels. Levels of messenger RNAs
(mRNAs) encoding carboxylesterase 1 (CES1) to CES6 were
measured to determine which CES was involved in the M2
metabolism. CES3 (also known as triglyceride hydrolase [TGH]
and CES1D) mRNA levels were decreased in a dose-dependent
and time-dependent manner after TCDD exposure while CES6
(also known as CES2A) mRNA slightly decreased (Figure 3A).
The attenuation of CES3 expression was dependent on hepatic
AhR/ARNT expression, while that of the CES6 expression was
not, although the changes were lower in Ahr/ mice (Figures
3B and 3C). In addition, nondenaturing gel electrophoresis indi-
cated that TCDD lowered hepatic CES3 protein and activity
levels in a hepatic AhR/ARNT-dependent manner (Figures
3D–3F). Furthermore, overexpression of CES3 in HEK293 cells
enhanced the M2 metabolic activity, while CES6 did not (Fig-
ure 3G). These results suggest that CES3 catalyzes the M2
hydrolytic reaction and is a key factor for TCDD-induced alter-
ations of serum metabolites.
Figure 3. TCDD Exposure Decreased Car-
boxylesterase 3 Levels in the Liver, Medi-
ating M2 Hydrolysis
(A–C) qPCR analysis of CES mRNAs in the liver
(C57BL/6, A; Ahr/, B; ArntDLiv, C). Expression
was normalized to 18S ribosomal RNA. Each bar
represents the mean value and SD (n = 4–5). OIL,
TCDD(+), and TCDD(++) denotes vehicle, 10, and
200 mg/kg TCDD, respectively. D3 and D7 indicate
3 days and 7 days after TCDD injection, respec-
tively. Significance was determined by one-way
ANOVA with Dunnett’s test (A) or Bonferroni’s test
(B and C). *p < 0.05; **p < 0.01; ***p < 0.001; NS,
not significant.
(D–F) Nondenaturing gel electrophoresis of the
liver microsomal fraction (C57BL/6, D; Ahr/,
E; ArntDLiv, F). Nondenaturing gel electrophoresis
and CES staining were performed as described in
the Experimental Procedures. Arrows indicate
CES3 proteins.
(G) M2 hydrolase activity of cells transformed with
CES3. The hydrolase activity of cells was esti-
mated as described in the Experimental Proce-
dures. Hepa1c1 cells were transfected with empty,
CES3 expression, and CES6 expression vectors,
respectively. Each bar represents the average
value (n = 2).
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Activation of TGFb-SMAD3 and IL6-STAT3 Signaling
Decreased CES3 expression was not observed in primary hepa-
tocytes after 20 nM of TCDD exposure, although the hepato-
cytes showed induction of CYP1A2 expression (Figure 4A),
indicating that the AhR signaling pathway was intact. Proinflam-
matory cytokines are known to regulate gene expression in liver.
TCDD-induced expression of the mRNAs encoding tumor
necrosis factor a (TNFa), interleukin 6 (IL6), and transforming
growth factor b (TGFb) in liver was found in an AhR/ARNT-
dependent manner (Figures 4B–4D); the mRNA encoding IL1b
was not induced in TCDD-treated ArntF/F mice. In addition,
induction was also observed 3 days after TCDD injection (data
not shown). TCDD-exposed liver showed a significant increase
of IL6 and active TGFb proteins and a slight increase of TNFa
protein (Table S4). Thus, the influence of TNFa, IL6 and TGFb
on hepatic CES3 expression was investigated with primary
hepatocytes. Both IL6 (100 ng/ml) and TGFb (10 ng/ml) exposure
decreased the CES3 mRNA levels and TNFa (100 ng/ml) expo-
sure increased expression, under conditions where expression
of bonafide target genes (suppressor of cytokine signaling 3
[SOCS3] for IL6, nitric oxide synthase 2 [iNOS] for TNFa, andCell Metabolism 16, 634–644,collagen type I a 1 [COL1A1] for TGFb,
respectively) were induced (Figure 4E).
Luciferase reporter assays suggested
that the Ces3 gene promoter region
(1398 to 699) had a negative regula-
tory element since constitutive luciferase
activity of the Ces3-1.4k reporter is lower
than that of Ces3-0.7k reporter (Fig-
ure S4A). Both IL6 and TGFb exposure
attenuated luciferase activity of theCes3-1.4k reporter with putative signal transducer and acti-
vator of transcription 3 (STAT3)- and MAD homolog 3
(SMAD3)-binding sites in Hepa1c1 cells, but they did not affect
the Ces3-0.7k reporter without the sites (Figure 4F). In addition,
introduction of STAT3 or SMAD3 also attenuated the activity of
the Ces3-1.4k reporter, but not that of the Ces3-0.7k reporter
(Figures S4B and S4C). Attenuation of this construct by IL6
or TGFb was diminished by mutation of the STAT3- and/
or SMAD3-binding sites (Figure 4F). Cotreatment with IL6
(50 ng/ml) and TGFb (5 ng/ml) markedly decreased CES3
mRNA levels in primary hepatocytes, compared to the IL6
or TGFb alone (Figure 4G). Furthermore, in vivo chromatin
immunoprecipitation (ChIP) assays indicated SMAD3- and
STAT3-binding to the Ces3 gene promoter region after TCDD
administration (Figure 4H). These results suggest that TCDD-
activated IL6 and TGFb signaling attenuates CES3 expression
in the liver. The effect of IL6 and TGFb in Ahr/ hepatocyte
cultures was not investigated. However, TCDD exposure
decreased hepatic CCAAT/enhancer binding protein a (CEBPa)
expression, which controls Ces3 gene expression, in an
AhR/ARNT-dependent manner (Figures S4D and S4E). In-
terestingly, TGFb attenuated hepatocyte CEBPa expressionNovember 7, 2012 ª2012 Elsevier Inc. 637
Figure 4. TCDD-Stimulated Activation of IL6
and TGFb Signaling Attenuated Ces3 Gene
Transcription in the Liver
(A) CES3 and CYP1A2 mRNA levels in primary
hepatocytes after TCDD exposure. Each bar
represents the mean value and SD (n = 4).
(B–D) qPCR analysis of proinflammatory cyto-
kine mRNAs in the liver (C57BL/6, B; Ahr/,
C; ArntDLiv, D). Each bar represents themean value
and SD (n = 4–5).
(E) CES3 mRNA in primary hepatocytes after
exposure to proinflammatory cytokine (100 ng/ml
of IL6, 100 ng/ml of TNFa, or 10 ng/ml of TGFb).
Each bar represents themean value and SD (n = 3).
SOCS3, iNOS, and COL1A1 mRNA expression
was used as positive controls for IL6, TNFa, and
TGFb, respectively.
(F) Ces3 gene promoter assay. Each bar
represents the mean value and SD (n = 6). IL6
(100 ng/ml) or TGFb (5 ng/ml) was added to
Hepa1c1 cells transfected with the reporter
vectors. Significance was determined by unpaired
t test (left) and one-way ANOVAwith Dunnett’s test
(right).
(G) CES3 mRNA in primary hepatocytes
after coexposure to proinflammatory cytokines
(50 ng/ml IL6 and 5 ng/ml TGFb). Each bar repre-
sents the mean value and SD (n = 3). Significance
was determined by one-way ANOVA with Bonfer-
roni’s test.
(H) In vivo ChIP assays. Each bar represents
the average value (n = 2). The Ppia gene was
used as negative target gene of STAT3 and
SMAD3.
See also Table S4 and Figures S4 and S5.
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ure S4G); IL6 did not alter levels of CEBPa. Thus, TGFb also
decreased hepatic CES3 levels indirectly through attenuation
of CEBPa expression.
TCDD Elevated Hepatic H2O2 through Induction
of Xanthine Dehydrogenase and NADPH Oxidase 2
in an AhR/ARNT-Dependent Manner
Hepatic H2O2 levels were measured to investigate the mecha-
nism by which TCDD stimulates proinflammatory cytokine
activation. The TCDD-enhanced hepatic H2O2 levels were
dose and AhR/ARNT dependent (Figure S5A). The mRNAs
encoding xanthine dehydrogenase (XDH, also known as
xanthine oxidase) and NOX2 (NADPH oxidase 2, also known
as cytochrome b245-b), the major sources of oxidative stress,
were measured in livers. The induction of these genes by TCDD
was dose dependent and was clearly observed at 3 days
and 7 days after TCDD administration (Figure S5B); the induc-638 Cell Metabolism 16, 634–644, November 7, 2012 ª2012 Elsevier Inc.tion of XDH and NOX2 expression was
also AhR/ARNT dependent (Figures
S5C and S5D). Furthermore, TCDD ex-
posure induced XDH and NOX2 in
primary hepatocytes (Figure S5E). These
results support the view that TCDD
directly induces XDH and NOX2 expres-sion via AhR/ARNT signaling and enhances oxidative stress in
the liver.
Changes in Serum Az Metabolites and the Related
Hepatic Gene Expression Patterns Are Associated with
Steatohepatitis
TCDD is known to increase hepatic triglyceride (TG) levels.
Indeed, TCDD increased the hepatic TG levels in a dose-
dependent [OIL, TCDD(+) and TCDD(++) was 9.2 ± 0.8, 36.2 ±
7.8, and 73.0 ± 11.0 mg/mg liver, respectively] and AhR/ARNT-
dependent manner (Figure 5A). Serum TG and free fatty acids
were not changed in an AhR/ARNT-dependent manner (Table
S5). In view of this result, a possible relationship between the
serum TCDD marker M2 and fatty liver was investigated using
2 fatty liver animal models, db/db mice and methionine- and
choline-deficient (MCD) diet-fed mice. Hepatic TG levels were
elevated in both mouse models compared to the controls
(Figure 5B). The serum M2 levels were enhanced in the MCD
Figure 5. TCDD-Induced Hepatic Alter-
ations in Az Monoester Metabolism Were
Also Detected in Another Steatohepatitis
Model, but Not in a Simple Steatosis Model
(A and B) Hepatic TG levels in C57BL/6 (A), db/db,
and MCD diet-treated mice (B). Oil, TCDD(+), and
TCDD(++) denote vehicle, 10 mg/kg TCDD, and
200 mg/kg TCDD, respectively. Significance was
determined by one-way ANOVA with Dunnett’s
test (C57BL/6) or Bonferroni’s test (Ahr/ and
ArntDLiv) and unpaired t test (db/db and MCD).
Each bar represents the mean value and SD (n =
3–6). **p < 0.01; ***p < 0.001; NS, not significant.
(C–E) Serum M2 levels (C) and qPCR analysis of
hepatic TCDD-related gene expression in db/db
(D) and MCD diet-treated mice (E). Significance
was determined by unpaired t test. Each bar
represents the mean value and SD (n = 3–6). *p <
0.05; **p < 0.01; ***p < 0.001; NS, not significant.
See also Table S5 and Figure S6.
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phenomenonwas also observedwithM1 levels (data not shown).
The CES3 mRNA expression was attenuated in the MCD diet-
treated mice with steatohepatitis, but not in the db/db mice
with simple steatosis (Figures 5D and 5E). In addition, induction
of XDH, NOX2, and TGFb expression was only observed in the
MCD steatohepatitis model (Figures 5D and 5E). TCDD-, AhR/
ARNT-, and MCD diet-dependent changes in hepatic expres-
sion of other TG-related genes were not observed (Figure S6).
MCD diet also resulted in a 3-fold induction of CYP1A1 mRNA
suggesting a small amount of AhR/ARNT signaling activation in
the livers of these mice, considerably less than the massive acti-
vation of AhR/ARNT signaling seen in TCDD-treated mice (data
not shown). These results indicate the importance of hepatic
CES3 expression in Az monoester metabolism and suggest
that the metabolic alterations are related to induction of XDH,
NOX2, and TGFb expression in livers with steatohepatitis.
Hepatic CES3 Overexpression Attenuated SerumM2/Az
Ratios
To investigate whether CES3 catalyzes M2 hydrolytic reaction
in vivo, a recombinant adenovirus expressing mouse CES3Cell Metabolism 16, 634–644,was generated (Figure S7A). The adeno-
virus (2 3 109 pfu/mouse) produced
robust expression of CES3 in the liver
without increased serum ALT levels
4 days after injection (Figures S7B and
S7C). Adenovirus was injected 4 days
before the mice were killed (Figures
S7D and S7E) and enhanced both hepatic
CES3 mRNA and protein expression
(Figures 6A–6D) and decreased serum
M2/Az ratios (Figures 6E and 6F) in
TCDD- and MCD-induced liver injury,
although the ratio was not significantly
decreased in methionine- and choline-
supplemented (MCS) control diet-treated
mice (Figure 6F). In addition, with and
without CES3 overexpression, hepaticCES3 mRNA levels were negatively correlated with serum M2/
Az ratios (Figures 6G and 6H). These results strongly suggest
that hepatic CES3 mediates M2 hydrolysis in vivo. Interestingly,
forced expression of CES3 attenuated the increase in serum ALT
levels after MCD treatment, but not after TCDD exposure
(Figures 6I and 6J). Furthermore, liver histology revealed that
CES3 overexpression alleviated both TCDD- and MCD-induced
steatohepatitis (Figures 6K and 6L) and decreased the enhanced
hepatic TGFb mRNA levels (Figures S7F and S7G). This
observation may suggest a link between CES3, TGFb, and
steatohepatitis.
DISCUSSION
The current study demonstrated that TCDD increased serum
Az monoester levels after proinflammatory cytokine-induced
changes in expression of hepatic CES3 (Figure 7). For further
determination of the global changes in serum metabolites after
TCDD administration, the serum metabolome of the TCDD-
exposed mice was interrogated and compared with that of the
controls. UPLC-ESI-TOFMS, in conjunction with a PLS-DA,
revealed changes in serum metabolites after TCDD exposureNovember 7, 2012 ª2012 Elsevier Inc. 639
Figure 6. Forced Expression of Hepatic CES3 Expression with Adenovirus Attenuated TCDD- and MCD-Induced Hepatic Alterations in Az
Monoester Metabolism
(A and B) Hepatic CES3 mRNA levels after injection of adenovirus expressing mouse CES3 (Ad-CES3) or control adenovirus (Ad-GFP) under condition of TCDD-
(A) and MCD diet- (B) induced liver injury. Expression was normalized to 18S ribosomal RNA. Each bar represents the mean value and SD (n = 3–4). OIL, TCDD,
MCS, and MCD denote vehicle, 200 mg/kg TCDD, methionine-, and choline-supplemented diet, and methionine-, and choline-deficient diet, respectively.
(C and D) Western blotting of hepatic CES3 protein after injection of Ad-CES3 and Ad-GFP to mice treated with TCDD (C) and MCD diet (D).
(E and F) Serum M2/Az ratios after injecting Ad-CES3 and Ad-GFP to mice treated with TCDD (E) and MCD diet (F). The value was presented as fold to
OIL_Ad-GFP (E) or MCS_Ad-GFP (F). Each bar represents the mean value and SD (n = 3–4). Significance was determined by one way-ANOVA with Bonferroni’s
test. *p < 0.05; NS, not significant.
(G and H) Correlation between hepatic CES3 mRNA levels and serum M2/Az ratios without (G) and with CES3 overexpression (H). The correlation r and p values
were estimated by Pearson correlation test.
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Figure 7. Putative Mechanism by which
Dioxin Mediates Hepatic Alterations in M2
Metabolism
Yellow and blue arrows represent increased
and decreased, respectively. Pink and green
arrows are presented as enhanced and attenuated
gene expression, respectively. Bold and broken
lines denote acceleration and deceleration,
respectively.
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and M2) were elevated. Levels of the M1 and M2 in serum were
increased in a time-dependent manner after TCDD exposure,
even with low-dose (10 mg/kg) TCDD, which did not significantly
increase serum ALT and AST levels. These results suggest that
Az monoesters are early indicators of dioxin exposure.
TCDD affects a variety of organs (Rifkind, 2006). The
changes of serum metabolites were diminished in ArntDLiv
mice, but not in ArntDIE mice, indicating that the TCDD-medi-
ated metabolic alterations were related to hepatic AhR/ARNT
signal transduction. Liver microsomes demonstrated hydrolysis
of Az monoesters and showed decreased activity in an AhR/
ARNT-dependent manner after TCDD injection. These results
indicate that attenuation of hepatic hydrolase activity is cor-
related with increased Az monoesters in serum. The hydrolytic
enzyme, carboxylesterase, was considered a candidate en-
zyme catalyzing the hydrolysis of Az monoesters. Among
several forms expressed in mice, CES3 (also called TGH)
expression was decreased in a hepatic AhR/ARNT-dependent(I and J) Serum ALT levels after injecting Ad-CES3 and Ad-GFP to mice treated with TCDD (I) and MCD diet (J
3–4). Significance was determined by one-way ANOVA with Bonferroni’s test. *p < 0.05; NS, not significant.
(K and L) Liver histology with hematoxylin and eosin staining. Scale bars represent 100 mm.
See also Figure S7.
Cell Metabolism 16, 634–644,manner and overexpression of CES3 in
HEK293 cells catalyzed hydrolysis of Az
monoesters in microsomes. In addition,
forced expression of CES3 in the liver
attenuated the TCDD-induced serum
ratios of M2 to Az. Furthermore, the
ratios showed a negative correlation
with the CES3 mRNA levels. Thus, a
major reason for the TCDD-mediated
increase in serum Az monoester levels
is likely due to decreased hepatic
CES3/TGH expression.
TCDD exposure generates inflamma-
tion in the liver (Lu et al., 2011; Shen
et al., 1991) and TCDD-induced liver
injury is dependent on AhR/ARNT
signaling. Hepatocyte AhR/ARNT activa-
tion can trigger liver injury and alter
serum Az monoester levels in mice.
TCDD exposure did not lower CES3
expression in primary hepatocytes, thus
indicating that the effect is indirect.
However, it was previously reported that
TCDD can induce expression of XDHand NOX2 in primary hepatocytes in an AhR/ARNT-dependent
manner (Sugihara et al., 2001). TCDD also raised H2O2 levels
in the liver, where XDH and NOX2 expression was induced.
XDH and NOX2 are known to generate reactive oxygen species
(ROS) (Kale, 2003; Lam et al., 2010), such as H2O2, and then
ROS can in turn stimulate proinflammatory cytokine activation
(Jaeschke, 2011). Induction of IL6 and TGFb expression was
also dependent on AhR/ARNT in the liver. Furthermore, IL6
and TGFb decreased CES3 expression through STAT3 and
SMAD3 signaling, respectively. Cotreatment with IL6 and
TGFb resulted in a marked attenuation of CES3 expression in
hepatocytes, suggesting an interaction between IL6 and
TGFb, as previously reported (Yamamoto et al., 2001). Induction
of TNFa mRNA expression was also observed in the liver.
However, different from IL6 and TGFb, TNFa protein was not
significantly increased in the liver. The slight enhancement of
TNFa protein, which can induce CES3 expression in hepato-
cytes, may not affect CES3 expression. Additionally, H2O2
(400 mM for 6 hr)-induced CES3 suppression was not observed). Each bar represents the mean value and SD (n =
November 7, 2012 ª2012 Elsevier Inc. 641
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support the view that AhR/ARNT activation by TCDD leads to
attenuation of CES3 expression in the liver through XDH/
NOX2-ROS-cytokine signaling.
Simple steatosis is different from steatohepatitis in proinflam-
matory cytokine activation (Tanaka et al., 2012). MCD diet-fed
mice (nonalcoholic steatohepatitis [NASH] model) showed
similar alterations in serum Az monoesters and hepatic gene
expression profiles to the TCDD-exposed mice, but db/db
mice with simple steatosis did not. TCDD was also known to
lead to steatohepatitis (Lu et al., 2011) and stimulate proinflam-
matory cytokine activation in the present study. Among these
cytokines, the TCDD-induced TGFb mRNA levels were highly
correlated with serum Az monoester levels and hepatic CES3,
NOX2, and XDH mRNA levels. In addition, induction of TGFb
expression was observed in the MCD diet-treated mice with
elevated serum Az monoesters after increased hepatic XDH
and NOX2 mRNA levels and decreased hepatic CES3 mRNA
levels; elevated IL6 expression was not observed. Furthermore,
forced expression of CES3 in the liver attenuated the increase in
serum ALT levels and hepatic TGFb mRNA levels and alleviated
NASH induced by MCD diet. Although further studies are
required to determine how TGFb contributes to steatohepatitis,
decreased hepatic CES3 activity might reflect TGFb activation
under hepatic inflammation. The TGFb-mediated decrease in
hepatic CES3 activation can mainly cause an elevation of serum
Az monoesters.
This study demonstrated that decreased CES3 expression by
TCDD exposure was due to increased proinflammatory cytokine
signaling. Lower CES3 expression was also associated with
steatohepatitis. CES3 expression can be detected bymonitoring
its metabolism in vivo, as demonstrated with the altered levels of
Az monoesters. This could lead to a diagnostic test for early
signs of dioxin toxicity and steatohepatitis that appear before
the onset of liver damage as revealed by an increase in serum
AST and ALT levels.
EXPERIMENTAL PROCEDURES
Materials
Nonane acid mono-(3-hydroxypropyl) ester, nonanedioic acid mono-(2-
hydroxypropyl) ester, and nonanedioic acid mono-(2-hydroxy-1-methylethyl)
ester were synthesized as described in Supplemental Experimental Proce-
dures. TNFa and IL6 were purchased from Sigma-Aldrich (St. Louis, MO)
and TGFb was from R&D Systems (Minneapolis, MA).
Cell Culture
HEK293 and COS-1 cells were grown at 37C with 5% CO2 in RPMI 1640 and
DMEM (Invitrogen, Grand Island, NY) supplemented with 10% fetal bovine
serum (Gemini Bio-Products, Woodland, CA), respectively. For gain of
CES3- and CES6-overexpressing cells, HEK293 and COS-1 cells were trans-
fected by Fugene 6 (Invitrogen) with CES3- and CES6-expression vector
(Origene Technology, Rockville, MD).
Animals and Diets
Ahr/ (Fernandez-Salguero et al., 1995), ArntF/F (Tomita et al., 2000), ArntDLiv
(Shah et al., 2009), and ArntDIE (Ito et al., 2007) mice were previously
described. C57BL/6NCr and db/db mice were purchased from The Jackson
Laboratory (Bar Harbor, ME). Mice were housed in temperature- and light-
controlled rooms and were given water and pelleted NIH-31 chow ad libitum.
In the TCDD studies, mice (7 to 9 weeks old) were injected intraperitoneally
with TCDD solution (10% dimethylsulfoxide [DMSO]/corn oil as vehicle).642 Cell Metabolism 16, 634–644, November 7, 2012 ª2012 ElsevierMCD and the control MCS diet (Tanaka et al., 2012) were purchased from
Dyets (Bethlehem, PA) and given to C57BL/6NCr mice (7 to 9 weeks old)
for 4 weeks ad libitum. db/db and the control C57BL/6NCr mice were sacri-
ficed at the age of 12 to 16 weeks. All animal studies were carried out in
accordance with Institute of Laboratory Animal Resources (ILAR) guidelines
and approved by the National Cancer Institute Animal Care and Use
Committee.
Chemical Detection and Quantification
Serum was prepared with Serum Separator Tubes (Becton, Deckinson and
Company, Flanklin Lakes, NJ). The serum was diluted with nine volumes of
66% acetonitrile and centrifuged twice at 18,000 g for 20 min to remove insol-
uble materials. UPLC-ESI-QTOFMS analysis was preformed as previously
reported (Matsubara et al., 2011). The eluant was introduced by electrospray
ionization into the mass spectrometer (Q-TOF Premier [Waters, Milford, MA])
operating in either negative or positive electrospray ionization modes. To
quantify the levels of Az and its monoesters, an Acquity UPLC system coupled
with a XEVO triple-quadrupole tandemmass spectrometer (Waters) was used.
Purified standard of each compound was used for quantitation. Multiple
reaction monitoring (MRM) was employed and the following MRM transitions
were used: 187/ 125 (Az), 245/125 (metabolite M2a), 245/187 (metabolite
M2c), and 275/190 (Chlorpropamide, internal standard). An Acquity UPLC
BEH C18 column (1.7 mm, 2.1 3 150 mm, Waters) was used to separate the
samples. The mobile phase was comprised of 0.1% aqueous formic acid
(A) and acetonitrile containing 0.1% formic acid (B). The initial gradient of
2% B was held for 1.5 min, then linearly increased to 60% B at 12 min, and
then to 99% B at 18 min. The gradient was held at 99% B for 1 min, and
then returned to initial conditions for 2 min for column equilibration. Flow
rate was maintained at 0.3 ml/min and column temperature was maintained
at 50C throughout the run.
Data Processing and Multivariate Data Analysis
Data processing and multivariate data analysis were conducted as previously
reported (Matsubara et al., 2011). A PLS-DA, PCA, and contribution analyses
were performed with SIMCA-P+12 (Umetrics, Kinnelon, NJ).
RNA Analysis
RNA was extracted with TRIzol reagent (Invitrogen). Quantitative PCR (qPCR)
was performed with complementary DNA generated from 1 mg total RNA with
SuperScript II Reverse Transcriptase kit (Invitrogen). Primers were designed
with qPrimerDepot. All sequences are listed in Table S1. qPCR reactions
were carried out with SYBR green PCR master mix (Applied Biosystems,
Foster City, CA) in an ABI Prism 7900HT Sequence Detection System. Values
were quantified with the comparative CT method and normalized to 18S ribo-
somal RNA.
Detection of Carboxylesterase in Microsomal Fractions
Liver was homogenizedwith 100mMTris-HCl (pH 7.5) with a protease inhibitor
cocktail (Roche Diagnostics, Indianapolis, IN) for microsomal fractions. The
homogenate was centrifuged at 9,000 g, and then the supernatant was centri-
fuged at 105,000 g. The pellet was suspended with 10% Glycerol/100 mM
Tris-HCl (pH 7.5). Protein was quantified with the BCA Protein Assay Kit
(Termo, Rockford, IL). Microsomal proteins were separated with nondenatur-
ing gel electrophoresis and carboxylesterases detected with Fast Blue RR and
1-naphthyl acetate, as previously described (Yang et al., 2001). In brief, 10 mg
microsomal protein was subjected to nondenaturing gel electrophoresis (7.5%
acrylamide gel). The gel was washed for 30 min in 100 mM potassium phos-
phate buffer (pH 6.5), followed by incubation in the buffer with 1-naphthylace-
tate (5mM), and diazotized Fast Blue RR. Esterase staining is based on a black
and insoluble complex between the Fast Blue RR and 1-naphtol hydrolyzed
from 1-naphthylacetate.
Determination of Hydrolase Activity to M2
Hepatic microsomal protein (2 mg) was mixed with 50 ml 100 mM Tris-HCl
buffer (pH 7.4) including M2 as substrate (triplicate for each concentration),
and incubated at 37C for 10 min. One hundred microliters of 66% acetonitrile
with 4-chloropropamide (internal standard) was added to stop the reaction and
extract the metabolites. After vortexing for 1 min, the solution was centrifugedInc.
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detect the metabolites. The Vmax and Km were determined with Prism ver-
sion 5.0c (GraphPad Software, San Diego, CA). HEK293 cells expressing re-
combinant CES3 and CES6 were cultured in RPMI 1640 with M2 as substrate
for 24 hr. The medium was collected and 75% acetonitrile with 4-chloropropa-
mide (internal standard) was added to extract the metabolites. After vortexing
for 1 min, the solution was centrifuged at 18,000 g for 20 min. The supernatant
was subjected to the Xevo system to measure the metabolites. The hydrolase
activity to M2 was determined as production of the product Az from M2.
Preparation and Culture of Hepatocytes
Hepatocytes were prepared by general perfusion method with 2 mg/ml
collagenase (Matsubara et al., 2011). The viability of isolated hepatocytes
was checked with trypan blue dye exclusion and those with higher than
85% viability were used. The hepatocyte was incubated at 37C with 5%
CO2 in DMEM with 1% fetal bovine serum for 4 hr to attach on plate. For
starvation, the cells were preincubated in serum-free DMEM and exposed to
proinflammatory cytokines for 12 hr or TCDD/DMSO for 24 hr. These cells
were subjected to qPCR analysis.
Reporter Gene Assays
Ces3-1.4k andCes3-0.7k promoters were amplified and inserted into pGL4.10
vector (Promega, Fitchburg, WI). Mutation of putative STAT3- and SMAD3-
binding sites in theCes3-1.4k reporter vector was produced by PCRmutagen-
esis with PfuUltra HF (Stratagene, La Jolla, CA). The primer sequences are
listed in Table S1. The firefly luciferase reporter vectors (200 ng) were trans-
fected into Hepa1c1 cells seeded on 24-well plate, together with pGL4.74
vector (renilla luciferase vector, 10 ng) for normalization. Twelve hours after
transfection, IL6 or TGFb was added to the cells. Then 24 hr later, the cells
were lysed and subjected to measuring the activity with Dual-Luciferase assay
kit (Promega). The firefly luciferase activity was normalized to the renilla
luciferase activity.
In Vivo ChIP Assays
Mice were injected with 100 mg/kg TCDD or OIL (10% DMSO/90% corn oil) for
control. Four days after injection, the liver tissue was perfused with 2 mg/ml
collagenase and fixed at 37C with DMEM including 1% formaldehyde and
2 mM disuccinimityl glutarate. ChIP was performed with the Chromatin
Immunoprecipitation assay kit (Cell Signaling, Irvine, CA) with anti-SMAD3
(ab28379, Abcam, Cambridge, UK) and anti-STAT3 (#9132, Cell signaling)
antibodies. The immunoprecipitated DNA was subjected to qPCR. The primer
sequences are listed in Table S1. Values were quantified with the comparative
CT method and normalized to 2% input, and the data (fold activation) were
estimated as ratios to the OIL.
Generation of Adenovirus with CES3 Expression
The recombinant adenovirus expressingmouse CES3was prepared by Vector
BioLabs, Philadelphia, PA. The virus was amplified in HEK293 cells and
purified through two rounds of CsCl gradients. The titer was determined by
optical density and qPCR. The University of Michigan Vector Core facility
provided the control adenovirus expressing green fluorescent protein (GFP)
(Ad-GFP). Adenovirus was diluted in 0.9% sterile saline just prior to injection
and injected from tail vein with 2 3 109 pfu in the total volume of 200 ml.
Mice were sacrificed 4 days after adenovirus injection.
Western Blotting
For whole-cell extracts, liver was homogenized with RIPA buffer. The
homogenate was centrifuged at 18,000 g. The supernatant was collected
and subjected to western blotting. The samples were boiled for 5 min,
loaded in each lane (40 mg protein), separated in 4%–15% gradient gel, and
then transferred to PVDF using standard western blotting techniques. The
membranes were incubated with a goat polyclonal antibody against CES3
(sc-82554, Santa Cruz Biotechnology, Santa Cruz, CA).
Histological Analysis
Small blocks of liver tissue were immediately fixed in 10% neutral formalin and
embedded in paraffin. Sections (4 mm thick) were stained with hematoxylin andCell Meosin. At least three discontinuous liver sections were evaluated for each
mouse.
Statistical Analysis
Statistical analysis was performed with Prism version 5.0c (GraphPad
Software). A p value of less than 0.05 was considered as significant difference.
Results are expressed as the mean value and SD.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
five tables, and seven figures and can be found with this article online at
http://dx.doi.org/10.1016/j.cmet.2012.10.006.
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